Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1978-1-27
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0032-5473
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
53 Suppl 3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
79-82
|
pubmed:dateRevised |
2009-10-22
|
pubmed:meshHeading |
pubmed-meshheading:928271-Administration, Oral,
pubmed-meshheading:928271-Adult,
pubmed-meshheading:928271-Atenolol,
pubmed-meshheading:928271-Half-Life,
pubmed-meshheading:928271-Heart Rate,
pubmed-meshheading:928271-Humans,
pubmed-meshheading:928271-Kinetics,
pubmed-meshheading:928271-Male,
pubmed-meshheading:928271-Physical Exertion,
pubmed-meshheading:928271-Propanolamines
|
pubmed:year |
1977
|
pubmed:articleTitle |
Investigation of chronic dosing regimens of atenolol.
|
pubmed:publicationType |
Journal Article
|